Mylan has previously fought against its competitor Teva Pharmaceutical Industries' application to the FDA for approval of its generic EpiPen
You have no items in your shopping cart.
You have no items in your shopping cart.
Mylan has previously fought against its competitor Teva Pharmaceutical Industries' application to the FDA for approval of its generic EpiPen
As a mother of two with over four years of practice as an emergency medicine physician, Sabry is uniquely qualified to share her perspectives about this issue.
For the last five years, Canadian patients have experienced drug shortages in hundreds of different medications. The majority of the shortages being seen in older inexpensive and generic drugs.